To the Editor: We commend the clinical update of Bergin and colleagues on the management of diabetes-related foot ulceration.1 We agree that a multidisciplinary approach is the best way to manage these complex wounds. However, we believe that the use of hyperbaric oxygen treatment (HBOT) for ulcers which have failed to respond to 3 months’ standard treatment justifies more prominent consideration.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Bergin SM, Gurr JM, Allard BP, et al. Australian Diabetes Foot Network: management of diabetes-related foot ulceration — a clinical update. Med J Aust 2012; 197: 226-229. <MJA full text>
- 2. Löndahl M, Fagher K, Katzman P. What is the role of hyperbaric oxygen in the management of diabetic foot disease? Curr Diab Rep 2011; 11: 285-293.
- 3. Löndahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010; 33: 998-1003.
- 4. Hawkins GC, Bennett MH, van der Hulst AE. The outcome of chronic wounds following hyperbaric oxygen therapy: a prospective cohort study — the first year interim report. Diving Hyperb Med 2006; 36: 94-98.
- 5. Goldman RJ. Hyperbaric oxygen therapy for wound healing and limb salvage: a systematic review. PM R 2009; 1: 471-489.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.